Biosortia Pharma

5 articles about Biosortia Pharma

• Dr. John Ryals added to Biosortia Pharmaceutical Board of Directors

  9/11/2019

  Biosortia, a leader in the next frontier of drug discovery, accessing the enormous chemical and genomic potential of natural microbiomes, is pleased to announce the addition of leading metabolomics expert, Dr. John Ryals to the Board of Directors. 

• Leidos Biomedical Research And Biosortia Execute Memorandum Of Understanding

  8/15/2017

• Biosortia Announces Three New Oncology Research Projects Using Microbial Compounds

  5/9/2016

• Dublin Startup Biosortia Raises Cash and Moves HQ to San Diego for Johnson & Johnson Incubator But Expects to Expand in Ohio as Well

  1/4/2016

• Startup Biosortia Seeks CEO, Willing To Relocate HQ

  11/19/2015